Researchers at Florida State University College of Medicine have discovered a connection between anxiety-like behaviour in mice and aspartame, an artificial sweetener present in roughly 5,000 diet items and beverages.
Researchers have come up with fresh ideas for how microbes might assist humans in establishing colonies on the moon and Mars in response to the biochemical process by which cyanobacteria in Chile's Atacama Desert obtain nutrients from rocks.
According to research, patients taking efgartigimod, a medication being tested for use in the treatment of chronic primary immune thrombocytopenia (ITP), showed a significantly greater improvement in platelet counts, which are necessary for clotting and stopping bleeding, compared to those t
Researchers from the University at Buffalo have developed a new strontium-loaded scaffold that can be customised to fit any size dental implant and may aid in patient healing and tissue attachment.
Union Minister for Environment, Forest and Climate Change, Bhupender Yadav held a review meeting in Kuno National Park with a team of researchers, scientists, and forest officials on Sunday.
Although many emerging adults find social interactions enjoyable on days with increased time alone, those who seek solitude as an escape from stress or unpleasant social circumstances may not, according to the results of a new study by University at Buffalo researchers.
Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
Researchers revealed why neighbours frequently make noises that are the source of great discomfort to us, ranging from the sound of stomping feet to the cacophony of things falling.
According to a recent analysis of data from more than 200 countries and regions, type 2 diabetes rates among adolescents and young people have dramatically grown globally between 1990 and 2019.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report